Analyzing Market Trends – A Closer Look at MDT Stock

By Harris Dyer • Sunday, December 29 15:16 • Permanent Link

Large-cap Health Care company Medtronic has moved -0.2% so far today on a volume of 2,987,723, compared to its average of 5,729,960. In contrast, the S&P 500 index moved -1.0%.

Medtronic trades -15.9% away from its average analyst target price of $96.0 per share. The 27 analysts following the stock have set target prices ranging from $82.0 to $112.0, and on average have given Medtronic a rating of buy.

If you are considering an investment in MDT, you'll want to know the following:

Medtronic's current price is 68.5% above its Graham number of $47.92, which implies that at its current valuation it does not offer a margin of safety
Medtronic has moved -2.5% over the last year, and the S&P 500 logged a change of 25.9%
Based on its trailing earnings per share of 3.27, Medtronic has a trailing 12 month Price to Earnings (P/E) ratio of 24.7 while the S&P 500 average is 29.3
MDT has a forward P/E ratio of 13.8 based on its forward 12 month price to earnings (EPS) of $5.85 per share
Its Price to Book (P/B) ratio is 2.11 compared to its sector average of 3.53
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Based in Galway, the company has 95,000 full time employees and a market cap of $103.53 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.